tiprankstipranks
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksStock ScreenerCompare StocksPenny Stock ScreenerTop Product Insights Stocks
Daily Updates
Daily Analyst RatingsTrending StocksTop Stock GainersTop Stock LosersMost Active StocksDividend StocksChatGPT Stocks
New
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
ETF Research Tools
ETF CenterETF ScreenerTop ETFs by Smart Score
New
Compare ETFsTop ETFs by AUM
ETFs On the Move
Top ETF GainersTop ETF LosersMost Active ETFs
ETF Ideas
S&P 500 Index ETFsNasdaq 100 Index ETFsS&P 500 Sector ETFsBond ETFsCommodity ETFsCurrency ETFsIndustry ETFs
Best Dividend StocksBest High Yield Dividend StocksDividend Aristocrats
New
Dividend Stock ComparisonDividend Calculator
Popular
Dividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
My PortfolioMy WatchlistMy PerformanceMy Portfolio AnalysisCrowd Insights
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
Education
TipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityCareersContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stock Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Stock Screener
Compare Stocks
Penny Stock Screener
Top Product Insights Stocks
Options Profit Calculator
New
Daily Updates
Daily Analyst Ratings
Trending Stocks
Top Stock Gainers
Top Stock Losers
Most Active Stocks
Dividend Stocks
ChatGPT Stocks
New
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
ETF Research Tools
ETF Center
ETF Screener
New
Top ETFs by Smart Score
New
Compare ETFs
Top ETFs by AUM
ETFs On the Move
Top ETF Gainers
Top ETF Losers
Most Active ETFs
ETF Ideas
S&P 500 Index ETFs
Nasdaq 100 Index ETFs
S&P 500 Sector ETFs
Bond ETFs
Commodity ETFs
Currency ETFs
Industry ETFs
Best Dividend Stocks
Best High Yield Dividend Stocks
Dividend Aristocrats
New
Dividend Stock Comparison
Dividend Calculator
Popular
Dividend Returns Comparison
Dividend Calendar
Crypto Center
Bitcoin
Ethereum
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
My Portfolio
My Watchlist
My Performance
My Portfolio Analysis
Crowd Insights
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
Education
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Careers
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
Plans & Pricing

ACST Stock Latest News

Acasti Pharma to proceed with Phase 3 study of GTX-104
The FlyAcasti Pharma to proceed with Phase 3 study of GTX-104
2M ago
ACST
Acasti Pharma names Prashant Kohli as CEO, succeeding Jan D’Alvise
The FlyAcasti Pharma names Prashant Kohli as CEO, succeeding Jan D’Alvise
2M ago
ACST
Acasti Pharma to delist shares on TSXV, confirms no exposure to SVB
The FlyAcasti Pharma to delist shares on TSXV, confirms no exposure to SVB
3M ago
ACST
SIVB
Biotech Alert: Searches spiking for these stocks today
The FlyBiotech Alert: Searches spiking for these stocks today
4M ago
ACST
NNVC
Acasti Pharma Reports Third Quarter 2023 Operational Results
Press ReleasesAcasti Pharma Reports Third Quarter 2023 Operational Results
4M ago
ACST
Acasti Pharma reports Q3 EPS (9c) vs (9c) last year
The FlyAcasti Pharma reports Q3 EPS (9c) vs (9c) last year
4M ago
ACST
Acasti receives extension to regain compliance with minimum bid requirement
The FlyAcasti receives extension to regain compliance with minimum bid requirement
4M ago
ACST
Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule
Press ReleasesAcasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule
4M ago
ACST
Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31
Press ReleasesAcasti Pharma to Present at Lytham Partners Investor Select Conference on January 31
5M ago
ACST
Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
Press ReleasesAcasti Pharma to Present at Sidoti Virtual Investor Conference on January 18
5M ago
ACST
Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures
Press ReleasesAcasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures
5M ago
ACST
Acasti says preliminary results of GTX-102 study met all outcome measures
The FlyAcasti says preliminary results of GTX-102 study met all outcome measures
5M ago
ACST
Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia
Press ReleasesAcasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia
5M ago
ACST
Acasti Pharma announces preliminary resulst in study of GTX-101
The FlyAcasti Pharma announces preliminary resulst in study of GTX-101
6M ago
ACST
Acasti Pharma initiated with a Buy at EF Hutton
The FlyAcasti Pharma initiated with a Buy at EF Hutton
6M ago
ACST
Acasti Pharma initiated with a Buy at H.C. Wainwright
The FlyAcasti Pharma initiated with a Buy at H.C. Wainwright
6M ago
ACST
Acasti Pharma to Present at Q4 Investor Summit
Press ReleasesAcasti Pharma to Present at Q4 Investor Summit
7M ago
ACST
Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022
Press ReleasesAcasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022
7M ago
ACST
Acasti Announces Court Dismissal of Stockholder Litigation
Press ReleasesAcasti Announces Court Dismissal of Stockholder Litigation
8M ago
ACST
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
Press ReleasesAcasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
8M ago
ACST
Acasti Pharma to Participate in the Lytham Partners Fall 2022 Investor Conference
Press ReleasesAcasti Pharma to Participate in the Lytham Partners Fall 2022 Investor Conference
9M ago
ACST
Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia
Press ReleasesAcasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia
9M ago
ACST